GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitae Corp (OTCPK:NVTAQ) » Definitions » Shiller PE Ratio
中文

Invitae (Invitae) Shiller PE Ratio

: (As of Today)
View and export this data going back to 2015. Start your Free Trial

Shiller PE for Stocks: The True Measure of Stock Valuation


Invitae Shiller PE Ratio Historical Data

The historical data trend for Invitae's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invitae Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Invitae Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Diagnostics & Research subindustry, Invitae's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invitae Shiller PE Ratio Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Invitae's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Invitae's Shiller PE Ratio falls into.



Invitae Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Invitae's E10 for the quarter that ended in Sep. 2023 is calculated as:

For example, Invitae's adjusted earnings per share data for the three months ended in Sep. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-3.42/129.8595*129.8595
=-3.420

Current CPI (Sep. 2023) = 129.8595.

Invitae Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201312 -0.546 98.326 -0.721
201403 -0.607 99.695 -0.791
201406 -0.708 100.560 -0.914
201409 -0.848 100.428 -1.097
201412 -0.514 99.070 -0.674
201503 -1.090 99.621 -1.421
201506 -0.760 100.684 -0.980
201509 -0.710 100.392 -0.918
201512 -0.760 99.792 -0.989
201603 -0.800 100.470 -1.034
201606 -0.770 101.688 -0.983
201609 -0.770 101.861 -0.982
201612 -0.690 101.863 -0.880
201703 -0.640 102.862 -0.808
201706 -0.660 103.349 -0.829
201709 -0.570 104.136 -0.711
201712 -0.780 104.011 -0.974
201803 -0.660 105.290 -0.814
201806 -0.470 106.317 -0.574
201809 -0.450 106.507 -0.549
201812 -0.400 105.998 -0.490
201903 -0.470 107.251 -0.569
201906 -0.540 108.070 -0.649
201909 -0.820 108.329 -0.983
201912 -0.790 108.420 -0.946
202003 -0.990 108.902 -1.181
202006 -1.290 108.767 -1.540
202009 -0.780 109.815 -0.922
202012 -1.340 109.897 -1.583
202103 -0.560 111.754 -0.651
202106 0.530 114.631 0.600
202109 -0.910 115.734 -1.021
202112 -0.900 117.630 -0.994
202203 -0.800 121.301 -0.856
202206 -10.870 125.017 -11.291
202209 -1.270 125.227 -1.317
202212 -0.410 125.222 -0.425
202303 -0.770 127.348 -0.785
202306 -0.780 128.729 -0.787
202309 -3.420 129.860 -3.420

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Invitae  (OTCPK:NVTAQ) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Invitae Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Invitae's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Invitae (Invitae) Business Description

Traded in Other Exchanges
Address
1400 16th Street, San Francisco, CA, USA, 94103
Invitae Corp operates as a genetic information company in diagnostic and research industry. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions.
Executives
Ana J. Schrank officer: Chief Financial Officer 1400 16TH STREET, SAN FRANCISCO CA 94103
Robert M. Guigley officer: Chief Commercial Officer 1400 16TH STREET, SAN FRANCISCO CA 94103
Robert Iv Dickey officer: See Remarks 320 WEST MERMAID LANE, PHILADELPHIA PA 19118
Jeff Parsons officer: See remarks 2575 AUGUSTINE DRIVE, SANTA CLARA CA 95054
Robert L Nussbaum officer: Chief Medical Officer 458 BRANNAN STREET, SAN FRANCISCO CA 94107
Thomas Brida officer: General Counsel 458 BRANNAN STREET, SAN FRANCISCO CA 94107
Robert F. Werner officer: Chief Accounting Officer 2500 FABER PLACE, PALO ALTO CA 94303
Yafei Wen officer: Chief Financial Officer 1400 16TH STREET, SAN FRANCISCO CA 94103
Kenneth D. Knight officer: Chief Operating Officer 1400 16TH STREET, SAN FRANCISCO CA 94103
William H Osborne director 1415 WEST 22ND STREET, SUITE 1100, OAK BROOK IL 60523
Sean E George director, officer: CEO 458 BRANNAN STREET, SAN FRANCISCO CA 94107
Shelly D Guyer officer: Chief Financial Officer 1025 GREEN STREET, SAN FRANCISCO CA 94133
Katherine Stueland officer: Chief Commercial Officer 458 BRANNAN STREET, SAN FRANCISCO CA 94107
Geoffrey Crouse director 3130 GATEWAY DRIVE, P O BOX 5625, NORCROSS GA 30091-5625
Jason W. Myers director, other: President, Oncology C/O ARCHERDX, INC., 2477 55TH STREET, SUITE 202, BOULDER CO 80301

Invitae (Invitae) Headlines

From GuruFocus

Q3 2020 Invitae Corp Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2021 Invitae Corp Earnings Call Transcript

By GuruFocus Research 02-14-2024

Invitae Corp at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 02-14-2024

Q4 2021 Invitae Corp Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2021 Invitae Corp Earnings Call Transcript

By GuruFocus Research 02-14-2024

Invitae Corp at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 02-14-2024